Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Breast Cancer Res Treat ; 206(3): 575-583, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-38662118

RESUMO

PURPOSE: The skin and/or nipple-sparing approach has become an oncologically sound and desirable choice for women choosing mastectomy. Indocyanine green (ICG) perfusion imaging has been shown to reduce ischemic complications in mastectomy skin flaps. Immediate reconstruction requires a well-vascularized skin flap capable of tolerating full expansion. Identification of the perforating subcutaneous vessels to the skin envelope may allow for better and more consistent blood vessel preservation and flap perfusion. METHODS: The authors conducted an institutional review board-approved prospective study with 41 patients to assess the feasibility of using ICG perfusion imaging to visualize, cutaneously map, and preserve the vessels that supply the skin flap and nipple-areolar complex. For each patient, the number of vessels initially mapped, the number of vessels preserved, the extent to which each vessel was preserved, and the proportion of the flap with adequate perfusion (as defined by the SPY-Q > 20% threshold) was recorded and analyzed. RESULTS: Vessels were able to be identified and marked in a high majority of patients (90%). There was a moderate linear relationship between the number of vessels marked and the number preserved. Successful mapping of vessels was associated with lower rates of wound breakdown (p = 0.036). Mapping and preserving at least one vessel led to excellent flap perfusion (> 90%). No increase in complications was observed from utilizing ICG angiography preoperatively. CONCLUSION: This prospective study using preoperative ICG perfusion mapping demonstrated safety, feasibility, and good prognostic outcomes. LEVEL OF EVIDENCE: III.


Assuntos
Neoplasias da Mama , Verde de Indocianina , Mamilos , Humanos , Feminino , Mamilos/cirurgia , Mamilos/irrigação sanguínea , Pessoa de Meia-Idade , Neoplasias da Mama/cirurgia , Neoplasias da Mama/diagnóstico por imagem , Adulto , Idoso , Retalhos Cirúrgicos/irrigação sanguínea , Angiografia/métodos , Estudos Prospectivos , Mastectomia/métodos , Mastectomia/efeitos adversos , Pele/irrigação sanguínea , Pele/diagnóstico por imagem , Mamoplastia/métodos , Tratamentos com Preservação do Órgão/métodos
2.
Am J Pathol ; 180(3): 973-983, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22234173

RESUMO

Stress-induced premature senescence (SIPS) of endothelial cells (ECs) has emerged as a contributor to global EC dysfunction. One of the cellular abnormalities mechanistically linked to SIPS is lysosomal dysfunction. In this study, we examined the impact of a range of cardiovascular risk factors on the expression of sirtuin 1 (SIRT1), SIPS, and apoptosis, and we documented the role of SIRT1 in reduced EC and endothelial progenitor cell (EPC) viability. These findings were confirmed in mice with selective endothelial SIRT1 knockout. The effects of stressors could be partially mimicked by inducing lysosomal membrane permeabilization or inhibiting autophagy, and were reversed by a cathepsin inhibitor. We provide evidence that SIRT1 is an important substrate of cysteine cathepsins B, S, and L. An antioxidant/peroxynitrite scavenger, ebselen, prevented stress-induced SIRT1 depletion and subversion of autophagy by mitigating lysosomal dysfunction. In conclusion, our data advance the concept of "stem cell aging" by establishing the critical role of lysosomal dysfunction in the development of SIPS through the cathepsin-induced proteolytic cleavage of SIRT1, a mechanism linking cell stress to apoptosis and SIPS. Ebselen potently protects lysosomal membrane integrity, preventing cathepsin-induced cleavage of SIRT 1 in EPCs and blunting SIPS and apoptotic cell death induced by relevant cardiovascular stressors. The proposed mechanism of SIRT1 depletion in stress has all of the attributes of being a paradigm of SIPS of EPCs.


Assuntos
Doenças Cardiovasculares/etiologia , Catepsinas/farmacologia , Senescência Celular/efeitos dos fármacos , Células Endoteliais/efeitos dos fármacos , Sirtuína 1/metabolismo , Células-Tronco/efeitos dos fármacos , Animais , Apoptose/efeitos dos fármacos , Arginina/análogos & derivados , Arginina/farmacologia , Autofagia/efeitos dos fármacos , Azóis/farmacologia , Permeabilidade da Membrana Celular/fisiologia , Células Cultivadas , Colágeno Tipo I/farmacologia , Regulação para Baixo , Endotélio Vascular , Peróxido de Hidrogênio/farmacologia , Isoindóis , Lisossomos/metabolismo , Camundongos , Camundongos Knockout , Camundongos Transgênicos , Compostos Organosselênicos/farmacologia , Proteínas Recombinantes , Fatores de Risco , Sirtuína 1/deficiência , Estresse Fisiológico/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA